A pioneering pathology technology developed by the National Pathology Imaging Co‑operative (NPIC) is set for international deployment after securing a commercial agreement with precision cancer diagnostics firm Epredia.
Features
Proposal to use a new testing protocol to improve the cleaning of surfaces
Following their recent article in Pathology in Practice which proves the relationship between air contamination and surface contamination, Andrew Kemp and Denise Hanson ask how can this knowledge be used to improve cleaning, and reduce potential cross contamination and microbial resistance to disinfectants?
Pneumococcal disease surveillance in an evolving epidemiological landscape
Pneumococcal disease, caused by Streptococcus pneumoniae remains a serious health issue. Here, Carolyn Moonen and Markus Meyer examine how recent technological advances in identification of bacterial isolates and their serotypes are improving disease surveillance and treatment.
Products
New LIAISON tuberculosis assay improves efficiency and productivity
Diasorin and QIAGEN have announced the launch of the new CE-marked LIAISON QuantiFERON-TB Gold Plus II, a next-generation assay that redefines speed and throughput as an aid in the diagnosis of tuberculosis infection on LIAISON analyser systems.
Menarini introduces Coyote FlashDetect PCR device range
Menarini has added Coyote FlashDetect PCR to its range of diagnostic solutions. These scalable rapid PCR devices will enable users to gain high quality results within 35 minutes.
QIAGEN unveils QIAsymphony Connect at AMP 2025
QIAGEN has launched QIAsymphony Connect, the next generation of its widely adopted automated nucleic acid purification platform, at the 2025 AMP (Association for Molecular Pathology) annual meeting.
ProtonDx's Dragonfly evaluated for identifying hidden malaria cases
A new study has shown that Dragonfly, a low-cost, rapid, molecular testing platform is successfully able to detect asymptomatic malaria infections.
Latest Issues
Stago’s objective is to improve the health of as many people as possible by offering powerful biotechnology solutions for blood-based diagnostics.
We take a lean, confidence-building approach to digital connectivity – from our latest Coag.One middleware to our cyber-secure Connect.One capability for enhanced engineering and remote...
ECP 2026 - 38th European Congress of Pathology
Stockholmsmässan, Stockholm, Sweden
12-16 September, 2026
UK NEQAS Parasitology Symposium
UKHSA, 61 Colindale Avenue, London NW9 5EQ
18 September, 2026
UKHSA Conference 2026
Manchester Central, Manchester, M2 3GX
22-23 September, 2026
Cardiac Marker Dialogues
Technology and Innovation Centre, University of Strathclyde, 99 George Street, Glasgow, G1 1RD
24-25 September, 2026
46th European Congress of Cytology
Hilton Antwerp Old Town, Antwerp
4-7 October, 2026